Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia Treated with First- Versus Second-Generation Tyrosine Kinase Inhibitors.

chronic myeloid leukemia patient-reported outcome quality of life tyrosine kinase inhibitors

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
25 Oct 2020
Historique:
received: 28 09 2020
revised: 20 10 2020
accepted: 21 10 2020
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 30 10 2020
Statut: epublish

Résumé

The life expectancy of patients with chronic myeloid leukemia (CML) approaches that of the age-matched population and quality of life (QOL) issues are becoming increasingly important. To describe patients' characteristics and assess QOL, we delivered a 30-item core questionnaire, a 24-item CML-specific questionnaire, both from the European Organization for Research and Treatment of Cancer (EORTC), and additional health-related items to 350 patients. Among 193 patients who completed the questionnaires, 139 received either imatinib (

Identifiants

pubmed: 33113857
pii: jcm9113417
doi: 10.3390/jcm9113417
pmc: PMC7692789
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : undefined <span style="color:gray;font-size:10px;">undefined</span>
ID : no grant

Références

Eur J Cancer. 2015 Dec;51(18):2808-19
pubmed: 26602015
Leukemia. 2020 Apr;34(4):966-984
pubmed: 32127639
Eur J Cancer. 2017 May;77:48-56
pubmed: 28365527
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):170-179
pubmed: 27913477
Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):78-82
pubmed: 28082112
Lancet Haematol. 2015 May;2(5):e186-93
pubmed: 26688093
J Clin Oncol. 2016 Aug 20;34(24):2851-7
pubmed: 27325849
J Clin Oncol. 2016 Jul 10;34(20):2333-40
pubmed: 27217448
Arthritis Rheum. 1989 Sep;32(9):1153-9
pubmed: 2775323
J Clin Oncol. 2017 Jan 20;35(3):298-305
pubmed: 28095277
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Leukemia. 2013 Jun;27(6):1316-21
pubmed: 23459449
Clin Cancer Res. 2005 Jan 1;11(1):12-9
pubmed: 15671523
Support Care Cancer. 2013 Apr;21(4):1097-103
pubmed: 23179489
Leukemia. 2016 Aug;30(8):1648-71
pubmed: 27121688
Qual Life Res. 2014 Apr;23(3):825-36
pubmed: 24026634
Leukemia. 2016 May;30(5):1044-54
pubmed: 26837842
Leukemia. 2020 Feb;34(2):488-498
pubmed: 31477798
Eur J Cancer. 2001 Jul;37(11):1331-4
pubmed: 11435060
PLoS One. 2014 Mar 26;9(3):e93087
pubmed: 24671114
Br J Cancer. 2015 Feb 17;112(4):636-43
pubmed: 25602967
Lancet Oncol. 2018 Jun;19(6):747-757
pubmed: 29735299
Leukemia. 2017 Mar;31(3):593-601
pubmed: 27568522

Auteurs

Adi Shacham Abulafia (A)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva 49100, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Sivan Shemesh (S)

Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Lena Rosenmann (L)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva 49100, Israel.

Tamar Berger (T)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva 49100, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Avi Leader (A)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva 49100, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Giora Sharf (G)

Israeli CML Patients Organization, 5 Ehud Manor st., Netanya 4265952, Israel.

Pia Raanani (P)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva 49100, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Uri Rozovski (U)

Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva 49100, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Classifications MeSH